World's Best Scientists 2026 revealed!

D-Index & Metrics

Medicine

D-Index
76
Citations
31467
World Ranking
18634
National Ranking
623

Overview

Roberto Salgado is affiliated with the Peter MacCallum Cancer Centre in Australia and has contributed extensively to the fields of Medicine and Biochemistry, Genetics and Molecular Biology. Their primary research focus spans Oncology, Cancer Research, Pulmonary and Respiratory Medicine, Immunology, and Radiology, Nuclear Medicine and Imaging.

The scientist's work encompasses several major topics including Cancer Immunotherapy and Biomarkers, Cancer Genomics and Diagnostics, Breast Cancer Treatment Studies, Cancer Cells and Metastasis, HER2/EGFR in Cancer Research, Radiomics and Machine Learning in Medical Imaging, and Immunotherapy and Immune Responses.

Roberto Salgado's frequent coauthors include:

  • Sherene Loi
  • Christos Sotiriou
  • Hugo M. Horlings
  • Marleen Kok
  • Stefan Michiels

The researcher has published repeatedly in several prominent scientific journals with multiple publications in:

  • Cancer Research (21 publications)
  • Annals of Oncology (15 publications)
  • npj Breast Cancer (15 publications)
  • Clinical Cancer Research (13 publications)
  • Nature Communications (8 publications)

Some recent papers by Roberto Salgado include:

  • "The 2019 World Health Organization classification of tumours of the breast," 2020, Histopathology
  • "Assessment of Ki67 in Breast Cancer: Updated Recommendations From the International Ki67 in Breast Cancer Working Group," 2020, JNCI Journal of the National Cancer Institute
  • "Pembrolizumab plus chemotherapy as neoadjuvant treatment of high-risk, early-stage triple-negative breast cancer: results from the phase 1b open-label, multicohort KEYNOTE-173 study," 2020, Annals of Oncology
  • "The journey of tumor-infiltrating lymphocytes as a biomarker in breast cancer: clinical utility in an era of checkpoint inhibition," 2021, Annals of Oncology
  • "The tale of TILs in breast cancer: A report from The International Immuno-Oncology Biomarker Working Group," 2021, npj Breast Cancer

Best Publications

  • The evaluation of tumor-infiltrating lymphocytes (TILs) in breast cancer: recommendations by an International TILs Working Group 2014

    R. Salgado;C. Denkert;S. Demaria;N. Sirtaine

  • Pan-cancer analysis of whole genomes

    Peter J. Campbell;Gad Getz;Jan O. Korbel;Joshua M. Stuart

  • Tumor infiltrating lymphocytes are prognostic in triple negative breast cancer and predictive for trastuzumab benefit in early breast cancer: results from the FinHER trial

    S. Loi;S. Loi;S. Michiels;S. Michiels;R. Salgado;N. Sirtaine

  • Prognostic and Predictive Value of Tumor-Infiltrating Lymphocytes in a Phase III Randomized Adjuvant Breast Cancer Trial in Node-Positive Breast Cancer Comparing the Addition of Docetaxel to Doxorubicin With Doxorubicin-Based Chemotherapy: BIG 02-98

    Sherene Loi;Nicolas Sirtaine;Fanny Piette;Roberto Salgado

  • CD4+ follicular helper T cell infiltration predicts breast cancer survival

    Chunyan Gu-Trantien;Sherene Loi;Soizic Garaud;Carole Equeter

  • Single-cell profiling of breast cancer T cells reveals a tissue-resident memory subset associated with improved prognosis

    Peter Savas;Balaji Virassamy;Chengzhong Ye;Agus Salim;Agus Salim

  • Insertion-and-deletion-derived tumour-specific neoantigens and the immunogenic phenotype: a pan-cancer analysis

    Samra Turajlic;Samra Turajlic;Kevin Litchfield;Hang Xu;Rachel Rosenthal

  • Clinical relevance of host immunity in breast cancer: from TILs to the clinic

    Peter Savas;Roberto Salgado;Carsten Denkert;Christos Sotiriou

  • Neoantigen-directed immune escape in lung cancer evolution

    Rachel Rosenthal;Rachel Rosenthal;Elizabeth Larose Cadieux;Roberto Salgado;Maise Al Bakir

  • Assessing Tumor-Infiltrating Lymphocytes in Solid Tumors: A Practical Review for Pathologists and Proposal for a Standardized Method from the International Immuno-Oncology Biomarkers Working Group Part 2 TILs in Melanoma, Gastrointestinal Tract Carcinomas, Non–Small Cell Lung Carcinoma and Mesothelioma, Endometrial and Ovarian Carcinomas, Squamous Cell Carcinoma of the Head and Neck, Genitourinary Carcinomas, and Primary Brain Tumors

    Shona Hendry;Roberto Salgado;Thomas Gevaert;Prudence A. Russell;Prudence A. Russell

  • Tumor-Infiltrating Lymphocytes and Prognosis: A Pooled Individual Patient Analysis of Early-Stage Triple-Negative Breast Cancers

    Sherene Loi;Damien Drubay;Sylvia Adams;Giancarlo Pruneri

  • Assessing Tumor-infiltrating Lymphocytes in Solid Tumors: A Practical Review for Pathologists and Proposal for a Standardized Method from the International Immunooncology Biomarkers Working Group: Part 1: Assessing the Host Immune Response, TILs in Invasive Breast Carcinoma and Ductal Carcinoma in Situ, Metastatic Tumor Deposits and Areas for Further Research

    Shona Hendry;Roberto Salgado;Thomas Gevaert;Prudence A. Russell;Prudence A. Russell

  • Immune induction strategies in metastatic triple-negative breast cancer to enhance the sensitivity to PD-1 blockade: the TONIC trial.

    Leonie Voorwerk;Maarten Slagter;Hugo M. Horlings;Karolina Sikorska

  • RAS/MAPK activation is associated with reduced tumor-infiltrating lymphocytes in triple-negative breast cancer: therapeutic cooperation between MEK and PD-1/PD-L1 immune checkpoint inhibitors

    Sherene Loi;Sherene Loi;Sathana Dushyanthen;Paul A. Beavis;Roberto Salgado

  • Tumor-Infiltrating Lymphocytes and Associations With Pathological Complete Response and Event-Free Survival in HER2-Positive Early-Stage Breast Cancer Treated With Lapatinib and Trastuzumab A Secondary Analysis of the NeoALTTO Trial

    Roberto Salgado;Carsten Denkert;Christine Campbell;Peter Savas

  • The 2019 World Health Organization classification of tumours of the breast.

    Puay Hoon Tan;Ian Ellis;Kimberly Allison;Edi Brogi

  • Circulating interleukin-6 predicts survival in patients with metastatic breast cancer.

    Roberto Salgado;Sara Junius;Ina Benoy;Peter Van Dam

  • Melanoma-specific MHC-II expression represents a tumour-autonomous phenotype and predicts response to anti-PD-1/PD-L1 therapy

    Douglas B. Johnson;Monica V. Estrada;Roberto Salgado;Violeta Sanchez

  • Update on tumor-infiltrating lymphocytes (TILs) in breast cancer, including recommendations to assess TILs in residual disease after neoadjuvant therapy and in carcinoma in situ: A report of the International Immuno-Oncology Biomarker Working Group on Breast Cancer

    Maria Vittoria Dieci;Nina Radosevic-Robin;Susan Fineberg;Gert Van den Eynden

  • Origins and functional consequences of somatic mitochondrial DNA mutations in human cancer

    Y S Ju;L B Alexandrov;M Gerstung;I Martincorena

Frequent Co-Authors

Sherene Loi
Sherene Loi Peter MacCallum Cancer Centre
Christos Sotiriou
Christos Sotiriou Université Libre de Bruxelles
Stefan Michiels
Stefan Michiels University of Paris-Saclay
Denis Larsimont
Denis Larsimont Université Libre de Bruxelles
Carsten Denkert
Carsten Denkert Philipp University of Marburg
Giuseppe Viale
Giuseppe Viale University of Milan
Giancarlo Pruneri
Giancarlo Pruneri University of Milan
Karen Willard-Gallo
Karen Willard-Gallo Institut Jules Bordet
Martine Piccart
Martine Piccart Université Libre de Bruxelles

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Pursuing Medicine in the USA opens up several online degree and certification options outside the traditional MD path. These offer flexibility, cost-effectiveness, and new career opportunities for those interested in healthcare.

For those leaning toward pharmacy, online pharmacist programs provide a route to advanced roles without the need for onsite attendance. If you are interested in the growing field of health data and administration, consider an online bachelor's in health information management to prepare for positions managing vital medical information.

There is also strong demand for experts in insurance processing. Exploring billing and coding classes online can quickly get you job-ready for medical office support roles. Aspiring advanced practice nurses can check out the cheapest online fnp programs to become a Family Nurse Practitioner with flexible study options.

Each pathway offers different career outcomes, program lengths, and tuition costs, catering to various interests within the healthcare sector.

Best Scientists Citing Roberto Salgado

Trending Scientists